Protein kinase inhibitors: emerging pharmacophores 1997 - 2000
Author:
Publisher
Informa Healthcare
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/13543776.11.3.405
Reference41 articles.
1. Tyrosine kinase inhibitors in cancer treatment (Part II)
2. Current progress towards the development of tyrosine kinase inhibitors as anticancer agents
3. ATP site-directed competitive and irreversible inhibitors of protein kinases
4. Strategies toward the Design of Novel and Selective Protein Tyrosine Kinase Inhibitors
Cited by 82 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Novel Synthesis Method of Meriolin1;Academic Journal of Science and Technology;2023-03-21
2. Design, synthesis and cytotoxic evaluation of novel bis-thiazole derivatives as preferential Pim1 kinase inhibitors with in vivo and in silico study;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-02-02
3. A comprehensive review on acridone based derivatives as future anti-cancer agents and their structure activity relationships;European Journal of Medicinal Chemistry;2022-09
4. Activin A-Mediated Regulation of XT-I in Human Skin Fibroblasts;Biomolecules;2020-04-14
5. Pd(ii)-catalyzed intramolecular oxidative Heck dearomative reaction: approach to thiazole-fused pyrrolidinones with a C2-azaquarternary center;Organic & Biomolecular Chemistry;2016
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3